Samsung Biologics targets 15 banks for W3tr IPO
Samsung Biologics, which sent out a request for proposals for its South Korean IPO on April 29, is understood to have invited nine domestic and six international firms to submit bids.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts